SkinHealth Systems Inc. (SKIN) Financial Statements
SkinHealth Systems Inc. (SKIN) reported trailing twelve-month revenue of $290.0M (down 6.5% year on year) and net income of -$28.4M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $21.1M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
SKINSkinHealth Systems Inc.Follow SKIN — free
—
Price chart with a free account
- Market cap
- —
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Revenue | 0.26 | 0.37 | 0.40 | 0.33 | 0.30 | 0.29 | |
| Gross profit | 0.18 | 0.25 | 0.16 | 0.18 | 0.20 | 0.19 | |
| Research & development | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Operating income | -0.04 | -0.03 | -0.13 | -0.07 | -0.02 | -0.00 | |
| Pre-tax income | -0.38 | 0.05 | -0.10 | -0.03 | -0.01 | -0.02 | |
| Income tax | -0.00 | 0.00 | -0.00 | -0.00 | 0.00 | 0.00 | |
| Net income | -0.38 | 0.04 | -0.10 | -0.03 | -0.01 | -0.03 | |
| Diluted EPS ($) | -74.20 | -4.60 | -15.20 | -7.20 | -3.20 | -4.20 | |
| Diluted shares (bn) | 0.005 | 0.007 | 0.007 | 0.007 | 0.007 | — |
USD billions · SEC XBRL
SkinHealth Systems Inc. — questions
- What is SkinHealth Systems Inc.'s revenue?
- $290.0M over the twelve months to 2026-06-30, down 6.5% year on year, from its 10-Q and 10-K filings.
- What is SkinHealth Systems Inc.'s net income?
- -$28.4M over the twelve months to 2026-06-30.
- What is SkinHealth Systems Inc.'s free cash flow?
- $21.1M over the twelve months to 2026-06-30.
- What are SkinHealth Systems Inc.'s diluted earnings per share?
- $-4.20 over the twelve months to 2026-06-30.
Every figure on this page comes from SkinHealth Systems Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.